CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. GOVERNMENT REGULATIONS
3.3.1. Center for Veterinary Biologics(CVB)
3.4. PATENTS ANALYSIS
3.4.1. PATENT ANALYSIS BY YEAR
3.4.2. PATENT ANALYSIS BY REGION
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure
3.5.2. Restraints
3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary vaccines on human and animal health
3.5.3. Opportunities
3.5.3.1. Advancement in vaccine products
3.5.3.2. Vaccine products for hybrid animals
CHAPTER 4 ANIMAL VACCINES MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ATTENUATED VACCINES
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. INACTIVATED VACCINES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. SUBUNIT VACCINES
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. TOXOID VACCINES
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. CONJUGATE VACCINES
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. RECOMBINANT VACCINES
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.8. DNA VACCINES
4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast
CHAPTER 5 ANIMAL VACCINES MARKET, BY ANIMAL TYPE
5.1. OVERVIEW
5.2. COMPANION ANIMALS
5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals
5.3. CATTLE
5.3.1. Market size and forecast
5.4. PIGS
5.4.1. Market size and forecast
5.5. POULTRY
5.5.1. Market size and forecast
5.6. SHEEP
5.6.1. Market size and forecast
CHAPTER 6 ANIMAL VACCINES MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size & forecast
6.2.6. Mexico market size & forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size & forecast
6.3.5. France market size & forecast
6.3.6. UK market size & forecast
6.3.7. Italy market size & forecast
6.3.8. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size & forecast
6.4.5. China market size & forecast
6.4.6. Australia market size & forecast
6.4.7. India market size & forecast
6.4.8. South Korea market size & forecast
6.4.9. Taiwan market size & forecast
6.4.10. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size & forecast
6.5.5. Turkey market size & forecast
6.5.6. Venezuela market size & forecast
6.5.7. Saudi Arabia market size & forecast
6.5.8. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. MERCK & CO., INC.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments
7.2. ZOETIS INC.
7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments
7.3. CEVA SANT ANIMALE
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.4. SANOFI S.A.
7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments
7.5. ROMVAC
7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.6. VAXXINOVA
7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.7. BIOVAC
7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments
7.8. MERIAL
7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance
7.9. ANICON LABOR GMBH
7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & developments